CureVac N.V. (CVAC)
NASDAQ: CVAC · IEX Real-Time Price · USD
2.665
+0.015 (0.57%)
At close: Apr 16, 2024, 4:00 PM
2.680
+0.015 (0.56%)
Pre-market: Apr 17, 2024, 5:13 AM EDT

CureVac Revenue

CureVac had revenue of $45.62M in the twelve months ending September 30, 2023, down -52.95% year-over-year. Revenue in the quarter ending September 30, 2023 was $17.54M with 56.40% year-over-year growth. In the year 2022, CureVac had annual revenue of $71.72M, a decrease of -38.72%.

Revenue (ttm)
$45.62M
Revenue Growth
-52.95%
P/S Ratio
13.08
Revenue / Employee
$50,461
Employees
904
Market Cap
596.65M USD

Revenue Chart

* The company reports in EUR currency but revenue data is shown in USD.

History

Fiscal Year End Revenue Change Growth
Dec 31, 202271.72M-45.31M-38.72%
Dec 31, 2021117.03M57.44M96.37%
Dec 31, 202059.60M40.03M204.56%
Dec 31, 201919.57M4.77M32.27%
Dec 31, 201814.79M--
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Cross Country Healthcare 2.02B
Novavax 983.71M
Fulgent Genetics 289.21M
Valneva SE 170.79M
SI-BONE 138.89M
Mesoblast 7.25M
Allogene Therapeutics 95.00K
Revenue Rankings